High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 2, 2012, Pages 192-195

  Hesseling, Anneke C ^a   Kim, S ^b   Madhi, S ^c   Nachman, S ^d   Schaaf, H S ^a   Violari, A ^e   Victor, T C ^f   McSherry, G ^g   Mitchell, C ^h   Cotton, M F ⁱ  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Children; HIV; Isoniazid prevention; Resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PLACEBO; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INHA GENE; KATG GENE; MALE; MARKER GENE; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; NEGRO; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RPOB GENE; SOUTH AFRICA; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84862934325     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0795     Document Type: Article

References (17)

1. Wiseman C A, Schaaf H S, Cotton M F, et al. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. Int J Tuberc Lung Dis 2011; 15: 770-775.
2. Elenga N, Kouakoussui K A, Bonard D, et al. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Cote d'Ivoire: ANRS 1278 study. Pediatr Infect Dis J 2005; 24: 1077-1082. (Pubitemid 43011064)
3. Kouakoussui A, Fassinou P, Anaky M F, et al. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast. Paediatr Respir Rev 2004; 5: 311-315. (Pubitemid 39462675)
4. Hesseling A C, Cotton M F, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
5. Cotton M F, Schaaf H S, Lottering G, Weber H L, Coetzee J, Nachman S. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12: 225-227. (Pubitemid 351212418)
6. Zar H J, Cotton M F, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007; 334: 136.
7. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV-infected persons. Cochrane Database Syst Rev 2004; (1): CD000171.
8. Comstock G W, Baum C, Snider D E Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979; 119: 827-830.
9. International Union Against Tuberculosis and Lung Disease. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
10. Schaaf H S, Marais B J, Hesseling A C, Gie R P, Beyers N, Donald P R. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006; 95: 523-528. (Pubitemid 43791572)
11. Madhi S A, Nachman S, Violari A, Kim S, et al; P1041 Study Team. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365: 21-31.
12. Warren R M, Streicher E M, Charalambous S, et al. Use of spoligotyping for accurate classification of recurrent tuberculosis. J Clin Microbiol 2002; 40: 3851-3853.
13. Grobusch M. Drug-resistant and extensively drug-resistant tuberculosis in southern Africa. Curr Opin Pulm Med 2010; 16: 180-185.
14. Schaaf H S, Marais B J, Hesseling A C, Brittle W, Donald P R. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009; 99: 1486-1490.
15. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402. (Pubitemid 38624845)
16. Sneag D B, Schaaf H S, Cotton M F, Zar H J. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J 2007; 26: 1142-1146. (Pubitemid 350190948)
17. Nicol M P, Workman L, Isaacs W, Munro J, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11: 819-824.